Structural and Chemical Profiling of the Human Cytosolic Sulfotransferases

The human cytosolic sulfotransfases (hSULTs) comprise a family of 12 phase II enzymes involved in the metabolism of drugs and hormones, the bioactivation of carcinogens, and the detoxification of xenobiotics. Knowledge of the structural and mechanistic basis of substrate specificity and activity is crucial for understanding steroid and hormone metabolism, drug sensitivity, pharmacogenomics, and response to environmental toxins. We have determined the crystal structures of five hSULTs for which structural information was lacking, and screened nine of the 12 hSULTs for binding and activity toward a panel of potential substrates and inhibitors, revealing unique “chemical fingerprints” for each protein. The family-wide analysis of the screening and structural data provides a comprehensive, high-level view of the determinants of substrate binding, the mechanisms of inhibition by substrates and environmental toxins, and the functions of the orphan family members SULT1C3 and SULT4A1. Evidence is provided for structural “priming” of the enzyme active site by cofactor binding, which influences the spectrum of small molecules that can bind to each enzyme. The data help explain substrate promiscuity in this family and, at the same time, reveal new similarities between hSULT family members that were previously unrecognized by sequence or structure comparison alone.

[1]  L. Pedersen,et al.  Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase , 2000, FEBS letters.

[2]  R. Weinshilboum,et al.  A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. , 2004, Pharmacogenetics.

[3]  K. A. Comer,et al.  Human Dehydroepiandrosterone Sulfotransferase , 1995 .

[4]  K. S. Arun,et al.  Least-Squares Fitting of Two 3-D Point Sets , 1987, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[5]  K. A. Comer,et al.  Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization. , 1995, Annals of the New York Academy of Sciences.

[6]  N. Liyou,et al.  Structure of a Human Carcinogen-converting Enzyme, SULT1A1 , 2003, The Journal of Biological Chemistry.

[7]  Mei Li,et al.  Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate. , 2005, Biochemical and biophysical research communications.

[8]  G. Pacifici Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. , 2004, International journal of clinical pharmacology and therapeutics.

[9]  Chi‐Huey Wong,et al.  Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. , 2004, Angewandte Chemie.

[10]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[11]  R. Shi,et al.  Identifying Androsterone (ADT) as a Cognate Substrate for Human Dehydroepiandrosterone Sulfotransferase (DHEA-ST) Important for Steroid Homeostasis , 2004, Journal of Biological Chemistry.

[12]  T. Nakayama,et al.  Highly conserved mouse and human brain sulfotransferases: molecular cloning, expression, and functional characterization. , 2002, Gene.

[13]  Jennifer L. Martin,et al.  The Structure of Human SULT1A1 Crystallized with Estradiol , 2005, Journal of Biological Chemistry.

[14]  T. P. Dooley Cloning of the human phenol sulfotransferase gene family: three genes implicated in the metabolism of catecholamines, thyroid hormones and drugs. , 1998, Chemico-biological interactions.

[15]  M. Coughtrie,et al.  Human Cytosolic Sulfotransferases , 2005 .

[16]  H. Glatt,et al.  Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. , 2002, The Journal of clinical endocrinology and metabolism.

[17]  P. Nordlund,et al.  Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination , 2006, Proceedings of the National Academy of Sciences.

[18]  R. Weinshilboum,et al.  Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. , 2004, Biochemical and biophysical research communications.

[19]  L. Pedersen,et al.  Crystal Structure of the Human Estrogen Sulfotransferase-PAPS Complex , 2002, The Journal of Biological Chemistry.

[20]  Sean R. Eddy,et al.  Profile hidden Markov models , 1998, Bioinform..

[21]  R. Weinshilboum,et al.  Catecholestrogen sulfation: possible role in carcinogenesis. , 2002, Biochemical and biophysical research communications.

[22]  L. Pedersen,et al.  Crystal structure of human catecholamine sulfotransferase. , 1999, Journal of molecular biology.

[23]  R. Laskowski SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions. , 1995, Journal of molecular graphics.

[24]  H. Glatt,et al.  Sulfotransferases and acetyltransferases in mutagenicity testing: technical aspects. , 2005, Methods in enzymology.

[25]  C. Falany,et al.  Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver. , 1998, Molecular pharmacology.

[26]  M. Zhou,et al.  Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate. , 2002, The Biochemical journal.

[27]  C. Falany,et al.  Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  A. Bochkarev,et al.  Crystal structures of human sulfotransferases SULT1B1 and SULT1C1 complexed with the cofactor product adenosine‐3′‐ 5′‐diphosphate (PAP) , 2006, Proteins.

[29]  C. Bron,et al.  Algorithm 457: finding all cliques of an undirected graph , 1973 .

[30]  C. Falany,et al.  Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. , 2000, The Biochemical journal.

[31]  T. Leyh,et al.  Transition State of the Sulfuryl Transfer Reaction of Estrogen Sulfotransferase* , 2006, Journal of Biological Chemistry.

[32]  Jennifer L. Martin,et al.  Human SULT1A SULTs , 2005 .

[33]  L. Pedersen,et al.  Crystal Structure of Human Cholesterol Sulfotransferase (SULT2B1b) in the Presence of Pregnenolone and 3′-Phosphoadenosine 5′-Phosphate , 2003, Journal of Biological Chemistry.

[34]  Jennifer L. Martin,et al.  Human sulfotransferases and their role in chemical metabolism. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  H. Glatt,et al.  Sulfotransferases in the bioactivation of xenobiotics. , 2000, Chemico-biological interactions.

[36]  M. Coughtrie Catecholamine sulfation in health and disease. , 1998, Advances in pharmacology.

[37]  H. Glatt,et al.  Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. , 2000, Endocrinology.

[38]  A. Hersey,et al.  X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3 , 1999, The Journal of Biological Chemistry.

[39]  R D Klausner,et al.  The mammalian gene collection. , 1999, Science.

[40]  Jennifer L. Martin,et al.  Active Site Mutations and Substrate Inhibition in Human Sulfotransferase 1A1 and 1A3* , 2004, Journal of Biological Chemistry.

[41]  Jaime Prilusky,et al.  Automated analysis of interatomic contacts in proteins , 1999, Bioinform..

[42]  R. Duggleby,et al.  Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. , 1999, Biochemistry.

[43]  Annabel E. Todd,et al.  Evolution of function in protein superfamilies, from a structural perspective. , 2001, Journal of molecular biology.

[44]  L. Pedersen,et al.  Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. , 2003, Environmental health perspectives.

[45]  E. Brown,et al.  Probing the active site of YjeE: a vital Escherichia coli protein of unknown function. , 2004, The Biochemical journal.

[46]  Masoud Vedadi,et al.  Screening for Ligands Using a Generic and High-Throughput Light-Scattering-Based Assay , 2006, Journal of biomolecular screening.

[47]  K. A. Comer,et al.  Cloning and expression of human liver dehydroepiandrosterone sulphotransferase. , 1993, The Biochemical journal.

[48]  B. Everitt Cluster Analysis of Subjects, Hierarchical Methods , 2005 .

[49]  R. Weinshilboum,et al.  Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes , 2004, The Pharmacogenomics Journal.

[50]  A. D. Rodrigues,et al.  Sulfotransferase 1E1 is a low km isoform mediating the 3-O-sulfation of ethinyl estradiol. , 2004, Drug metabolism and disposition: the biological fate of chemicals.